Catheter Precision Inc. (NYSE American: VTAK), an innovative U.S. medical device firm focused on electrophysiology products, announced on May 7, 2024, a purchase order from the University of California San Diego Health System (UCSD) for its revolutionary LockeT product. Physicians, purchasing departments, and hospital staff are currently evaluating the LockeT product, recognizing the potential advantages of incorporating it into the overall UCSD health system.
On May 6, 2024, the stock slightly declined but closed on normal volume, still positioned above its 10-, 20-, 50-, and 200-Day Moving Averages (DMA), suggesting it is in breakout territory. Presently, it is trading in the mid fifty-cent range, with a 52-week high of $1.33, which may be approached in the near future, marking it as a stock to keep an eye on.
This purchase order follows another announcement on April 24 by Catheter Precision for the LockeT product, purchased by HCA Healthcare Inc. (NYSE: HCA). HCA Healthcare Inc. is one of the largest healthcare service providers in the United States, generating revenues of $64 billion in 2023. HCA Healthcare Inc. is considered one of the more discerning organizations in the healthcare industry regarding product evaluations. Therefore, the approval of the LockeT product within HCA’s national healthcare system marked a significant milestone for Catheter Precision.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
